Prevent Cardiac Surgery Associated AKI Trial

PHASE2RecruitingINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

July 18, 2024

Primary Completion Date

June 17, 2027

Study Completion Date

June 17, 2028

Conditions
Renal FailureCoronary Artery DiseaseSurgerySurgery-Complications
Interventions
DRUG

CoQ10 1200 mg orally with Glutathione 1000 mg orally

This is the intervention to assess efficacy of CoQ10 and Glutathione in prevention of cardiac surgery associated acute kidney injury

DRUG

Group B: Placebo CoQ10 orally and Placebo Glutathione orally

A placebo to exactly match the CoQ10 will be made with white gelatin empty capsules containing cellulose AND a placebo to exactly match the L-Glutathione will be made with white gelatin empty capsules containing cellulose.

Trial Locations (1)

20037

RECRUITING

George Washington University Hospital, Washington D.C.

All Listed Sponsors
lead

George Washington University

OTHER